Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load.

Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG.

Neurology. 2015 Feb 3;84(5):496-9. doi: 10.1212/WNL.0000000000001204. Epub 2014 Dec 31.

2.

Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.

Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DM.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):601-12. doi: 10.1111/nan.12178. Epub 2015 Apr 30.

3.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1.

4.

Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsy.

Miller JA, Spyropoulos A, Jaros E, Galban-Horcajo F, Whittaker RG, Willison HJ.

J Neuromuscul Dis. 2014;1(2):191-195.

PMID:
27858774
5.

The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.

Reeve A, Meagher M, Lax N, Simcox E, Hepplewhite P, Jaros E, Turnbull D.

J Neurosci. 2013 Jun 26;33(26):10790-801. doi: 10.1523/JNEUROSCI.3525-12.2013.

6.

Elderly individuals with FTLD.

Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R.

JAMA Neurol. 2013 Mar 1;70(3):412-3. doi: 10.1001/jamaneurol.2013.1649. No abstract available.

PMID:
23478838
7.

Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.

Lax NZ, Gnanapavan S, Dowson SJ, Alston CL, He L, Polvikoski TM, Jaros E, O'Donovan DG, Yarham JW, Turnbull DM, Dean AF, Taylor RW.

J Neuropathol Exp Neurol. 2013 Feb;72(2):164-75. doi: 10.1097/NEN.0b013e31828129c5.

PMID:
23334599
8.

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG.

J Neuropathol Exp Neurol. 2013 Jan;72(1):53-60. doi: 10.1097/NEN.0b013e31827c5710.

PMID:
23242284
9.

Microangiopathy in the cerebellum of patients with mitochondrial DNA disease.

Lax NZ, Pienaar IS, Reeve AK, Hepplewhite PD, Jaros E, Taylor RW, Kalaria RN, Turnbull DM.

Brain. 2012 Jun;135(Pt 6):1736-50. doi: 10.1093/brain/aws110. Epub 2012 May 9.

10.

Frontotemporal dementia in elderly individuals.

Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R.

Arch Neurol. 2012 Aug;69(8):1052-60. Review.

PMID:
22529248
11.

Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.

Davidson YS, Robinson AC, Hu Q, Mishra M, Baborie A, Jaros E, Perry RH, Cairns NJ, Richardson A, Gerhard A, Neary D, Snowden JS, Bigio EH, Mann DM.

Neuropathol Appl Neurobiol. 2013 Feb;39(2):157-65. doi: 10.1111/j.1365-2990.2012.01274.x.

12.

Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Lax NZ, Campbell GR, Reeve AK, Ohno N, Zambonin J, Blakely EL, Taylor RW, Bonilla E, Tanji K, DiMauro S, Jaros E, Lassmann H, Turnbull DM, Mahad DJ.

Arch Neurol. 2012 Apr;69(4):490-9. doi: 10.1001/archneurol.2011.2167.

13.

Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons.

Reeve AK, Park TK, Jaros E, Campbell GR, Lax NZ, Hepplewhite PD, Krishnan KJ, Elson JL, Morris CM, McKeith IG, Turnbull DM.

Arch Neurol. 2012 Mar;69(3):385-93. doi: 10.1001/archneurol.2011.2675.

PMID:
22410447
14.

Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia.

Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT.

Int J Geriatr Psychiatry. 2012 Dec;27(12):1267-74. doi: 10.1002/gps.3774. Epub 2012 Mar 2.

PMID:
22383167
15.

Atheromatous disease in small intracerebral vessels, microinfarcts and dementia.

Kalaria RN, Perry RH, O'Brien J, Jaros E.

Neuropathol Appl Neurobiol. 2012 Aug;38(5):505-8. doi: 10.1111/j.1365-2990.2012.01264.x. No abstract available.

PMID:
22376046
16.

Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.

Lax NZ, Hepplewhite PD, Reeve AK, Nesbitt V, McFarland R, Jaros E, Taylor RW, Turnbull DM.

J Neuropathol Exp Neurol. 2012 Feb;71(2):148-61. doi: 10.1097/NEN.0b013e318244477d.

17.

Sensory neuronopathy in patients harbouring recessive polymerase γ mutations.

Lax NZ, Whittaker RG, Hepplewhite PD, Reeve AK, Blakely EL, Jaros E, Ince PG, Taylor RW, Fawcett PR, Turnbull DM.

Brain. 2012 Jan;135(Pt 1):62-71. doi: 10.1093/brain/awr326. Epub 2011 Dec 20.

18.

Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease.

Krishnan KJ, Ratnaike TE, De Gruyter HL, Jaros E, Turnbull DM.

Neurobiol Aging. 2012 Sep;33(9):2210-4. doi: 10.1016/j.neurobiolaging.2011.08.009. Epub 2011 Sep 16.

PMID:
21925769
19.

Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes.

Baborie A, Jaros E, Griffiths TD, Momeni P, Perry R, Mann DM.

Neuropathol Appl Neurobiol. 2012 Feb;38(1):101-4. doi: 10.1111/j.1365-2990.2011.01209.x. No abstract available.

PMID:
21726271
20.

A harmonized classification system for FTLD-TDP pathology.

Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM.

Acta Neuropathol. 2011 Jul;122(1):111-3. doi: 10.1007/s00401-011-0845-8. Epub 2011 Jun 5. No abstract available.

21.

Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.

Elstner M, Morris CM, Heim K, Bender A, Mehta D, Jaros E, Klopstock T, Meitinger T, Turnbull DM, Prokisch H.

Acta Neuropathol. 2011 Jul;122(1):75-86. doi: 10.1007/s00401-011-0828-9. Epub 2011 May 4.

PMID:
21541762
22.

The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.

Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, Momeni P, Baborie A, Griffiths TD, Jaros E, Perry RH, Richardson A, Pickering-Brown SM, Neary D, Mann DM.

Acta Neuropathol. 2011 Jul;122(1):99-110. doi: 10.1007/s00401-011-0816-0. Epub 2011 Mar 20.

PMID:
21424531
23.

Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia.

Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT.

Neurobiol Aging. 2012 Jul;33(7):1228-36. doi: 10.1016/j.neurobiolaging.2010.12.015. Epub 2011 Feb 24.

PMID:
21353336
24.

What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?

Menon R, Baborie A, Jaros E, Mann DM, Ray PS, Larner AJ.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1412-4. doi: 10.1136/jnnp.2010.220947. Epub 2010 Nov 8. No abstract available.

PMID:
21084263
25.

Pathological correlates of frontotemporal lobar degeneration in the elderly.

Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis D, Pal P, Rollinson S, Pickering-Brown S, Thompson JC, Neary D, Snowden JS, Perry R, Mann DM.

Acta Neuropathol. 2011 Mar;121(3):365-71. doi: 10.1007/s00401-010-0765-z. Epub 2010 Oct 27.

PMID:
20978901
26.

Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene.

Elstner M, Morris CM, Heim K, Lichtner P, Bender A, Mehta D, Schulte C, Sharma M, Hudson G, Goldwurm S, Giovanetti A, Zeviani M, Burn DJ, McKeith IG, Perry RH, Jaros E, Krüger R, Wichmann HE, Schreiber S, Campbell H, Wilson JF, Wright AF, Dunlop M, Pistis G, Toniolo D, Chinnery PF, Gasser T, Klopstock T, Meitinger T, Prokisch H, Turnbull DM.

Ann Neurol. 2009 Dec;66(6):792-8. doi: 10.1002/ana.21780.

27.

Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions.

Betts-Henderson J, Jaros E, Krishnan KJ, Perry RH, Reeve AK, Schaefer AM, Taylor RW, Turnbull DM.

Neuropathol Appl Neurobiol. 2009 Feb;35(1):120-4. doi: 10.1111/j.1365-2990.2008.00981.x. No abstract available.

PMID:
19187065
28.

Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O'Brien JT.

Brain. 2009 Jan;132(Pt 1):195-203. doi: 10.1093/brain/awn298. Epub 2008 Nov 20.

PMID:
19022858
29.

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, Milton I.

Dement Geriatr Cogn Disord. 2008;26(1):32-42. doi: 10.1159/000141039. Epub 2008 Jun 25.

PMID:
18577885
30.

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK.

Synapse. 2007 Nov;61(11):903-11.

PMID:
17663455
31.

Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy.

Jaros E, Mahad DJ, Hudson G, Birchall D, Sawcer SJ, Griffiths PG, Sunter J, Compston DA, Perry RH, Chinnery PF.

Neurology. 2007 Jul 10;69(2):214-6. No abstract available.

PMID:
17620555
32.

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL.

J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1176-81. Epub 2007 Mar 12.

33.

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.

Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DM.

Acta Neuropathol. 2006 Nov;112(5):539-49. Epub 2006 Sep 26.

34.

Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.

Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, Lightowlers RN, Turnbull DM.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):359-73.

PMID:
16866982
35.

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.

Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM.

Nat Genet. 2006 May;38(5):515-7. Epub 2006 Apr 9.

PMID:
16604074
36.

Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia.

Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN.

Neuropathol Appl Neurobiol. 2006 Apr;32(2):103-18.

PMID:
16599940
37.

Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking.

Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK.

Neuropathol Appl Neurobiol. 2005 Oct;31(5):522-35.

PMID:
16150123
38.

[Appendiceal mucocele].

Pospísil I, Jaros E, Hadzi DN, Dvorák P.

Rozhl Chir. 2004 Sep;83(9):451-5. Czech.

PMID:
15615343
39.

[Cryolization in the inoperable breast carcinoma treatment].

Jaros E, Talábová Z, Megancová J.

Rozhl Chir. 2004 Aug;83(8):368-70. Czech.

PMID:
15552008
40.

Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.

Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E.

Neuropathol Appl Neurobiol. 2004 Dec;30(6):615-23.

PMID:
15541002
41.

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.

Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM, Trojanowski JQ.

Neurology. 2004 Oct 26;63(8):1376-84.

42.

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.

Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK.

J Neurol Sci. 2004 Oct 15;225(1-2):39-49.

PMID:
15465084
43.

SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies.

Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, Ravina B, Eerola J, Perry RH, Jaros E, Tienari P, Weiser R, Gwinn-Hardy K, Morris CM, Hardy J, Singleton AB.

Neurology. 2004 Aug 10;63(3):554-6.

PMID:
15304594
44.

alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Cairns NJ, Uryu K, Bigio EH, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2004 Sep;108(3):213-23. Epub 2004 May 28.

45.

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM, Trojanowski JQ.

Am J Pathol. 2004 Jun;164(6):2153-61.

46.

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL.

Neurology. 2004 May 11;62(9):1568-72.

PMID:
15136683
47.

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG.

Am J Psychiatry. 2004 May;161(5):843-9.

PMID:
15121649
48.

Temporal lobe pathology of human patients with neurofilament inclusion disease.

Cairns NJ, Jaros E, Perry RH, Armstrong RA.

Neurosci Lett. 2004 Jan 16;354(3):245-7.

PMID:
14700742
49.

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D.

Neuropsychopharmacology. 2004 Jan;29(1):108-16.

50.

[Intraoperative enteroscopy--personal experience from 1995 to 2002].

Kopácová M, Bures J, Rejchrt S, Siroký M, Bedrna J, Ferko A, Hajzman Z, Hladík P, Holecek T, Hroch T, Chochola M, Jandík P, Jaros E, Jon B, Kabelác K, Lesko M, Mergancová J, Pospísil I, Príborský J, Simkovic D, Spacek V, Trlica J, Vykouril L.

Cas Lek Cesk. 2003;142(5):303-6. Czech.

PMID:
12920797

Supplemental Content

Support Center